MedPath

Prospective Pharmaco-epidemiology Study

Phase 2
Registration Number
CTRI/2020/09/027526
Lead Sponsor
Central Council for Research in Ayurvedic Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Patients who have normal levels of liver and kidney function tests.

2. Patients willing to participate in the study for a minimum period of 1week to a maximum of 6 weeks.

Exclusion Criteria

1. Presence of renal or hepatic dysfunction.

2. Subjects who have a history of Cardiac Arrhythmia, Acute Coronary Syndrome, Myocardial Infarction, Stroke or Severe Arrhythmia, Carcinoma etc

3. Subjects with uncontrolled Pulmonary Dysfunction (asthmatic and COPD patients) or other concurrent severe disease.

4. Uncontrolled Diabetes Mellitus (HbA1C >8)

5. Any concurrent condition (medical, social or behavioral) that, in the opinion of the research team, would preclude or confound acquisition or interpretation of data or delivery of care.

6. Patient having the H/O intake of Rasaoushadhi in the past 6 weeks.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Development of an Ayurvedic informatics database of selected Rasausadhiâ??s in terms of clinical safety.Timepoint: 4 months after recruitment of patients
Secondary Outcome Measures
NameTimeMethod
Prospective documentation and analysis of information related with prescription trends of selected Rasausadhiâ??s in a structured format to draw the meaningful possible outcomes and conclusions.Timepoint: 4 months after recruitment of patients
© Copyright 2025. All Rights Reserved by MedPath